Document:

Exhibit 4.12

 

CONSULTING AGREEMENT

 

THIS AGREEMENT (the “Agreement”),
is made and entered into as of this 5th day of February 2021, by and between SH, an individual (“the “Consultant”),
and DIGERATI TECHNOLOGIES, Inc. a Nevada corporation, with offices at 825 W Bitters, Suite 104, San Antonio, Texas 78216 (the “Company”)
(each a “Party” and together the “Parties”).

 

WHEREAS,
Consultant is in the business of providing services for management consulting, business advisory and business development;

 

WHEREAS,
the Company deems it to be in its best interest to retain Consultant to render to the Company such services as may be needed;
and

 

WHEREAS,
the Parties desire to set forth the terms and conditions under which Consultant shall provide services to the Company.

 

NOW, THEREFORE,
in consideration of the mutual promises and covenants herein contained, and other valid consideration, receipt of which is
hereby acknowledged, the Parties agree as follows:

 

1. Term of Agreement

 

The Agreement
shall remain in effect from the date hereof through the expiration of a period of six months from the date hereof (the “Term”),
and thereafter may be renewed upon the mutual written consent of the Parties.

 

2. Nature of
Services to be rendered

 

During
the Term and any renewal thereof, Consultant shall use its best efforts to: (a) provide the Company with corporate consulting
services in connection with business development including but not limited to making introductions to corporate financial
relations companies and other financial services; (b) introduce the Company to various securities dealers, investment
advisors, analysts, funding sources and other members of the financial community with whom it has established relationships,
and generally assist the Company in its efforts to enhance its visibility in the financial community, and (c) perform
research with respect to the Company, investors and the market for the benefit of the Company and at the Company’s
direction, including, but not limited to, paid third-party research, which such research costs shall be assumed by the
Consultant (collectively, the “Services”). It is acknowledged and agreed by the Company that Consultant carries
no professional licenses, and is not rendering legal advice or performing accounting services, the Services of Consultant
shall not be exclusive nor shall Consultant be required to render any specific number of hours or assign specific personnel
to the Company or its projects, however it is anticipated and agreed upon by both parties that considerable time and
resources will be required to fulfill the obligations to the Company under this Agreement. The Company and Consultant further
acknowledge that Consultant has not and shall not (i) negotiate for the sale of any the Company’s securities; (ii)
discuss details of the nature of the securities sold or whether recommendations were made concerning the sale of the
securities; (iii) engage in due diligence activities; (iv) provide advice relating to the valuation of or the financial
advisability of any investments in the Company; or (v) handle any funds or securities on behalf of the Company.

 

     

     

    

 

3. Not a Broker
or Dealer; Investment Advisor.

 

The
Company and Consultant acknowledges that Consultant is not a (i) a registered “broker” (“Broker”)
or “dealer” (“Dealer”) as such terms are defined in Section 3(a)(4) and 3(a)(5) of the Securities
Exchange Act of 1934, as amended (the “Exchange Act”), or (ii) an investment adviser (“Investment
Advisor”), as such term is defined in Section 202(a)(l 1) of the Investment Advisors Act of 1940, as amended, or comparable
state laws, and will not act to effect any transactions in securities for the account of the Company. With respect thereto and
notwithstanding anything set forth herein to the contrary, in connection with any introduction to financing, Consultant shall
not carry out any activity or function that (i) may be traditionally performed by or otherwise be deemed to include those of a
Broker, Dealer or Investment Adviser or (ii) would require Consultant to be registered as a Broker, Dealer, or Investment Advisor.

 

4.
Compensation.

 

In
consideration for services rendered, the Company hereby agrees to pay Consultant an engagement fee of 2,000,000 shares of the
Company’s Common Stock (the “Restricted Stock”) due, which such Restricted Stock shall be deemed earned
upon the execution hereof.

 

5. Indemnification.

 

(a)
Consultant shall indemnify and hold harmless the Company and its affiliates, and their respective officers, directors, employees,
stockholders, consultants, attorneys and agents, and each person, if any, who controls the Company within the meaning of the Securities
Act of 1933, as amended (the “Securities Act”) and the Exchange Act, against all losses, liabilities, claims,
damages and expenses whatsoever (including, but not limited to, all losses to the extent of the aggregate amount paid in settlement
of litigation, commenced or threatened, or of any claim whatsoever, if such settlement is effected with Consultant’s written
consent, which shall not be unreasonably withheld), and to reimburse the indemnified parties for all legal and other expenses
incurred in investigating, preparing or defending against any litigation commenced or threatened or any claim whatsoever, whether
or not resulting in any liability, to which the indemnified parties may become subject under any statute or at common law or otherwise,
aiising out of or based upon a breach of this agreement and actions taken or not taken by Consultant in connection with this Agreement.

 

(b)
If for any reason the foregoing indemnification is unavailable to the indemnified party or are insufficient to hold such
indemnified party harmless, then the indemnifying party shall contribute to the amount paid or payable by such indemnified
party as a result of such loss, liability, claim, damage or expense in such proportion as is appropriate to reflect not only
the relative benefits received by the indemnifying party on the one hand and such indemnified party on the other hand but
also the relative fault of the indemnifying party and such indemnified party, as well as any relevant equitable
considerations. These indemnification provisions shall be binding upon and shall inure to the benefit of any successors,
assigns, heirs and personal representatives of the indemnified parties. This indemnification provision shall survive any
termination of this Agreement.

 

    2

     

    

 

6. Compliance
with Securities Laws

 

The Parties
acknowledge and agree that the Company is subject to the requirements of the 1934 Act, and that the 1933 Act, the 1934 Act, the
rules and regulations promulgated thereunder and the various state securities laws (collectively, “Securities Laws”)
impose significant burdens and limitations on the dissemination of certain information about the Company by the Company and by
persons acting for or on behalf of the Company. Each of the Parties agrees to comply with all applicable Securities Laws in carrying
out its obligations under the Agreement; and without limiting the generality of the foregoing, the Company hereby agrees (i) all
information about the Company provided to the Consultant by the Company, which the Company expressly agrees may be disseminated
to the public by the Consultant in providing any business development or other services pursuant to the Agreement, shall not contain
any untrue statement of a material fact or omit to state any material fact necessary to make the statements made, in light of the
circumstances in which they were made, not misleading, (ii) the Company shall promptly notify the Consultant if it becomes aware
that it has publicly made any untrue statement of a material fact regarding the Company or has omitted to state any material fact
necessary to make the public statements made by the Company, in light of the circumstances in which they were made, not misleading,
and (iii) the Company shall promptly notify the Consultant of any “quiet period” or “blackout period” or
other similar period during which public statements by or on behalf of the Company are restricted by any Securities Law. Consultant
hereby agrees, to the full extent permitted by applicable law, to indemnify and hold harmless the Company for any damages caused
to Company by the Consultant’s breach or violation of any Securities Law.

 

7. Confidentiality;
Non-Disparagement

 

The nature and
terms of this Agreement are strictly confidential and Consultant agrees not to disclose the terms of the Agreement without
the prior written consent of the Company, except (i) to any person in Consultant’s immediate family or household, (ii)
to any counsel or financial advisor, (iii) as necessary in any legal proceedings in accordance with the terms and conditions
of this Agreement, (iv) to prepare and file income tax forms, or (v) pursuant to court order after notice to the Company.
Similarly, the Company agrees not to disclose the nature and terms of this Agreement, except as is necessary to obtain
approval of it, to inform consultants, attorneys and officials, in any relevant legal proceedings, in any public reporting
documents (to the extent required by law, rule or regulation and including all applicable securities laws and regulations),
and to prepare proper documentation in tax, legal, accounting and claim records.

 

    3

     

    

 

Each Party
shall not, and shall not cause any third party to, make any remarks or adverse statements in any form including in any and
all media (e.g., in writing, orally or on the internet via, among other things, blogs, message boards and social networks)
about the other Party, its officers, directors, affiliates, employees, and consultants (as applicable) that, (i) could
reasonably be construed as disparaging or defamatory, (ii) cast such entity or individual in a negative light, or (iii) harm
the other Party, its officers, directors, or employees’ current or prospective business plans. This is not meant to
restrict or inhibit any action compelled by courts of law or testimony on the part of either Party should the Party ever be
required to testify under oath regarding the other Party or any related individual, or prevent the Company from disclosing
information to the extent required by law, rule or regulation and including all applicable securities laws and regulations.
The Company shall give a neutral recommendation to any third-party employment inquiries.

 

At all times
following termination for any reason, Consultant shall not disclose any Confidential Information to anyone outside of the Company
or its affiliates, or use any Confidential Information for your own benefit or for the benefit of any third party. Nothing, however,
shall prohibit Consultant from using or disclosing Confidential Information to the extent required by law.

 

For purposes
of this Agreement, “Confidential Information” means information relating or belonging to the Company which is
confidential, proprietary, or a trade secret, including the following: (i) information regarding the Company’s business,
operations, assets, liabilities or financial condition; (ii) information regarding the Company’s pricing, sales, merchandising,
marketing, capital expenditures, costs, joint ventures, business alliances, purchasing or manufacturing; (iii) information regarding
the Company’s franchisees, consultants or representatives, including their identities, responsibilities, competence and compensation;
(iv) information regarding the Company’s current or prospective customers, including information regarding their purchasing
patterns; (v) information regarding the Company’s current or prospective vendors, suppliers, distributors or other business
partners; (vi) forecasts, projections, budgets and business plans regarding the Company; (vii) information regarding the Company’s
planned or pending acquisitions, divestitures or other business combinations; (viii) the Company’s h·ade secrets and
proprietary information; (ix) technical information, patent disclosures and applications, copyright applications, sketches, drawings,
blueprints, models, know-how, discoveries, inventions, improvements, techniques, processes, business methods, equipment, algorithms,
software programs, software source documents and formulae, in each case regarding the Company’s current, future or proposed
products or services (including infonnation concerning the Company’s research, experimental work, development, design details
and specifications, and engineering); and (x) the Company’s web site designs, web site content, proposed domain names, and
data bases. Confidential Information does not include information that lawfully is or becomes generally and publicly known outside
of the Company and its affiliates other than through Consultant’s breach of this Agreement or breach by another person of
some other obligation.

 

Consultant
agrees that, due to the unique nature of the Confidential Information, the unauthorized disclosure or use of the Confidential
Information will cause irreparable harm and significant injury to the Company, the extent of which will be difficult to ascertain
and for which there will be no adequate remedy at law. Accordingly, Consultant agrees that the Company, in addition to any other
available remedies, shall have the right to seek an injunction and other equitable relief enjoining any breach or threatened breach
of this Agreement, without the necessity of posting any bond or other security. The Company shall notify Consultant in writing
immediately upon Company becoming aware of any such breach or threatened breach, and shall provide a description of the confidential
information underlying its basis of belief that Consultant disclosed without authorization.

 

    4

     

    

 

8. Complete Release

 

Consultant,
for Consultant and Consultant’s predecessors, successors, assigns, and heirs, hereby agrees to discharge and release the
Company, parent companies, divisions, subsidiaries, employees, legal counsel, officers, directors, partners, shareholders, insurers,
companies, predecessors, successors, assigns, subrogees, trustees, trusts, administrators, :fiduciaries and representatives, if
any (collectively, the “Company Releasees”), of and from any and all federal, state, local, foreign and any other
jurisdiction’s statutory or common law claims (including claims for contribution and indemnification except where and as
separately provided under any pre-existing employment contract), causes of action, complaints, actions, suits, defenses, debts,
sums of money, accounts, covenants, controversies, agreements, promises, losses, damages, orders, judgments and demands of any
nature whatsoever, in law or equity, known or unknown, of any kind, including, but not limited to, claims or other legal forms
of action arising from the Consultants work with the Company, or from any other conduct, act, omission or failure to act, whether
negligent, intentional, with or without malice, that Consultant ever had, now has, may have, may claim to have, or may hereafter
have or claim to have, against the Company Releasees, including. without limitation. a release of any rights or
claims Consultant may have based on:

 

 

		i.	the Federal Civil Rights Acts of 1966, 1970, 1971, 1964
and 1991, as amended; the Age Discrimination in Employment Act of 1967, as amended; the Americans with Disabilities Act as amended;
the Rehabilitation Act of 1973; the Equal Pay Act of 1963; the Worker Adjustment Retraining and Notification Act;

 

		ii.	the laws of Texas concerning wages, employment and discharge;
any local, county or city employment laws; or any other law, rule, regulation or ordinance pertaining to a consulting relationship,
employment, or termination of employment;

 

		iii.	claims arising out of any legal restrictions of the right
to terminate the Consultant’s relationship with the Company such as wrongful or unlawful discharge or related causes of
action;

 

		iv.	intentional infliction of
emotional distress; or

 

		v.	violation of any contract express or implied.

 

    5

     

    

 

9. Complete Release;
No Future Lawsuits, Complaints Or Claims

 

Except as set
forth herein, Consultant shall not file any petitions, charges, complaints, grievances, lawsuits, or related documents with
any judicial or administrative agency or union relating to any matter released herein concerning the Company,
Consultant’s relationship with the Company, or Consultant’s termination therefrom. Consultant agrees to withdraw
any such actions which are pending. If any such actions are filed on Consultant’s behalf, Consultant shall not accept
any relief or recovery from such action. Although Consultant is not precluded by this Agreement from filing a charge of
discrimination with the Equal Employment Opportunity Commission or a state Commission on Human Rights, Consultant promises
never to seek any damages, remedies or other relief for Consultant personally (any right to which Consultant hereby waives)
with respect to any claim this Agreement purports to waive. Consultant further agrees to indemnify and hold the Company
harmless as to any amounts awarded to Consultant with respect to such claims. In the event that the Company performs its
obligations under this Agreement and is required to defend a lawsuit or charge of discrimination filed by Consultant or on
Consultant’s behalf that is in breach of this Agreement, Consultant shall be liable for all reasonable expenses
(including reasonable discovery and other court costs and reasonable attorneys’ fees) incurred in defending the same,
regardless of the outcome. In the event that the Company takes appropriate action pursuant to Consultant’s breach of
any provision of this Agreement, all of Consultant’s other obligations under this Agreement shall remain in full
force.

 

Except as
set forth herein, Company shall not to file any petitions, charges, complaints, grievances, lawsuits, or related documents with
any judicial or administrative agency or union relating to any matter released herein concerning the Consultant, Consultant’s
relationship with the Company, or Consultant’s termination therefrom. Company agrees to withdraw any such actions which are
pending. If any such actions are filed on Company’s behalf, Company shall not accept any relief or recovery from such action.
In the event that the Consultant takes appropriate action pursuant to Company’s breach of any provision of this Agreement,
all of Company’s other obligations under this Agreement shall remain in full force.

 

Consultant
acknowledges Consultant was not an employee of Company or its aforementioned affiliates and, as such, is not entitled to apply
for or receive Unemployment Compensation benefits.

 

10. General Provisions

 

(a)
Governing Law; Severability. This letter agreement shall be governed by and under the laws of the State of Texas, without
giving effect to conflicts of law principles. If any provision hereof is found invalid or unenforceable, that part shall be amended
to achieve as nearly as possible the same effect as the original provision and the remainder of this letter agreement shall remain
in full force and effect.

 

(b)
Disputes. Any dispute arising under or in any way related to this letter agreement shall be submitted to binding arbitration
by the American Arbitration Association in accordance with the Association’s commercial rules then in effect. The arbitration
shall be binding on the parties and the arbitration award may be confirmed by any court of competent jurisdiction.

 

    6

     

    

 

(c)
Entire Agreement. This letter agreement constitutes the entire agreement and final understanding of the parties with respect
to the subject matter hereof and supersedes and terminates all prior and/or contemporaneous understandings and/or discussions
between the parties, whether written or verbal, express or implied, relating in any way to the subject matter hereof. This letter
agreement may not be altered, amended, modified or otherwise changed in any way except by a written agreement, signed by both
parties.

 

(d)
Notices. Any notice or other communication pursuant hereto shall be given to a party at its address first written above
herein by (i) personal delivery, (ii) commercial overnight courier with written verification of receipt, or (iii) registered or
certified mail. If so mailed or delivered, a notice shall be deemed given on the earlier of the date of actual receipt or three
(3) days after the date of authorized delivery.

 

(e)
Counterparts. This letter agreement may be executed in counterparts, each one of which shall constitute an original and
all of which taken together shall constitute one document.

 

[SIGNATURE PAGE TO FOLLOW]

 

    7

     

    

 

	/s/ SH	 
	As Consultant	 
	 	 
	DIGERATI
    TECHNOLOGIES, INC. 	 
	 	 
	/S/ Arthur Smith	 
	CEO	 

 

[Signature Page to Consulting
Agreement]Exhibit 10.3

 

SECURITIES PURCHASE AGREEMENT

 

This SECURITIES PURCHASE AGREEMENT (the
“Agreement”), dated as of February 17, 2021, by and between DIGERATI TECHNOLOGIES, INC., a Nevada corporation,
with headquarters located at 825 W. Bitters, Suite 104, San Antonio, Texas 78216 (the “Company”), and each of the purchasers
listed on the signature page attached hereto (each a “Purchaser”).

 

WHEREAS:

 

A. The
Company and the Purchaser are executing and delivering this Agreement in reliance upon the exemption from securities registration
afforded by Section 4(a)(2) of the Securities Act of 1933, as amended (the “1933 Act”) and Rule 506(b) promulgated
by the United States Securities and Exchange Commission (the “SEC”) under the 1933 Act; and

 

B. Purchaser
desires to purchase from the Company, and the Company desires to issue and sell to the Purchaser, upon the terms and conditions
set forth in this Agreement, a Convertible Promissory Note of the Company, in the aggregate principal amount of $175,000.00 (as
the principal amount thereof may be increased pursuant to the terms thereof, and together with any note(s) issued in replacement
thereof or as a dividend thereon or otherwise with respect thereto in accordance with the terms thereof, in the form attached hereto
as Exhibit A (the “Note”), convertible into shares of common stock of the Company (the “Common Stock”),
upon the terms and subject to the limitations and conditions set forth in such Note.

 

NOW THEREFORE, in consideration
of the foregoing and of the agreements and covenants herein contained, and for other good and valuable consideration, the receipt
and sufficiency of which is hereby acknowledged, the Company and the Purchaser hereby agree as follows:

 

1. Purchase and Sale of Note.

 

a. Purchase of Note. On the Closing
Date (as defined below), the Company shall issue and sell to the Purchaser and the Purchaser agrees to purchase from the Company
the Note and the Shares, subject to the express terms of the Note, the Shares, and this Agreement as the case may be.

 

b. Form of Payment. On the Closing
Date (as defined below), (i)the Buyer shall pay the purchase price for the Note to be issued and sold to it at the Closing (as
defined below) (the “Purchase Price”) by wire transfer of immediately available funds to the Company, in accordance
with the Company’s written wiring instructions, against delivery of the Note in the principal amount equal to the Purchase
Price of $175,000.00, and (ii) the Company shall deliver such duly executed Note on behalf of the Company, to the Buyer, against
delivery of such Purchase Price.

 

c. Closing Date. Subject to the
satisfaction (or written waiver) of the conditions thereto set forth in Section 6 and Section 7 below, the date and time of the
issuance and sale of the Note, or a Subsequent Purchase (as the case may be) pursuant to this Agreement (each a “Closing
Date”) shall be 4:00 PM, Eastern Time on the date first written above, or such other mutually agreed upon time.

 

d. Closing. The closing of the transactions
contemplated by this Agreement (the “Closing”) shall occur on each Closing Date at such location as may be agreed to
by the parties (including via exchange of electronic signatures).

 

    1

     

    

 

2. Purchaser’s Representations and Warranties.
The Purchaser represents and warrants to the Company as of the Closing Date that:

 

a. Investment Purpose. As of
the Closing Date, the Purchaser is purchasing the Shares, the Note and the shares of Common Stock issuable upon conversion of
or otherwise pursuant to the Note and such additional shares of Common Stock, if any, as are issuable on account of interest
on the Note, and pursuant to this Agreement, such shares of Common Stock being collectively referred to herein as the
“Conversion Shares” and, collectively with the Note and the Shares, the “Securities”) for its own
account and not with a present view towards the public sale or distribution thereof, except pursuant to sales registered or
exempted from registration under the 1933 Act; provided, however, that by making the representations herein,
the Purchaser does not agree to hold any of the Securities for any minimum or other specific term and reserves the right to
dispose of the Securities at any time in accordance with or pursuant to a registration statement or an exemption under the
1933 Act.

 

b. Accredited Investor Status. The
Purchaser is an “accredited investor” as that term is defined in Rule 501(a) of Regulation D (an “Accredited
Investor”).

 

c. Reliance on Exemptions. The Purchaser
understands that the Securities are being offered and sold to it in reliance upon specific exemptions from the registration requirements
of United States federal and state securities laws and that the Company is relying upon the truth and accuracy of, and the Purchaser’s
compliance with, the representations, warrants, agreements, acknowledgments and understandings of the Purchaser set forth herein
in order to determine the availability of such exemptions and the eligibility of the Purchaser to acquire the Securities.

 

d. Information. The Purchaser and
its advisors, if any, have been, and for so long as any of the Securities remain outstanding will continue to be, furnished with
all materials relating to the business, finances, and operations of the Company and materials relating to the offer and sale of
the Securities which have been requested by the Purchaser or its advisors. The Purchaser and its advisors, if any, have been, and
for so long as the Note or Shares remains outstanding will continue to be, afforded the opportunity to ask questions of the Company
regarding its business and affairs. Notwithstanding the foregoing, the Company has not disclosed to the Purchaser any material
nonpublic information regarding the Company or otherwise, and will not disclose such information unless such information is disclosed
to the public prior to or promptly following such disclosure to the Purchaser. Neither such inquiries nor any other due diligence
investigation conducted by Purchaser or any of its advisors or representatives shall modify, amend or affect Purchaser’s
right to rely on the Company’s representations and warranties contained in Section 3 below.

 

e. Governmental Review. The Purchaser
understands that no United States federal or state agency or any other government or governmental agency has passed upon or made
any recommendation or endorsement of the Securities.

 

f. Transfer or
Re-sale. The Purchaser understands that (i) the sale or resale of the Note has not been as of the Issue Date hereof,
registered under the 1933 Act or any applicable state securities laws, and the Note or Conversion Shares may not be
transferred unless (a) they are sold pursuant to an effective registration statement under the 1933 Act; (b) the Purchaser
shall have delivered to the Company, at the cost of the Company, an opinion of counsel (which may be the Legal Counsel
Opinion (as defined below)) that shall be in form, substance, and scope customary for opinions of counsel in comparable
transactions to the effect that the Securities to be sold or transferred may be sold or transferred pursuant to an exemption
from such registration, which opinion shall be accepted by the Company; (c) they are sold or transferred to an
“affiliate” (as defined in Rule 144 promulgated under the 1933 Act (or a successor rule) (“Rule
144”)) of the Purchaser who agrees to sell or otherwise transfer them only in accordance with this Section 2(f) and who
is an Accredited Investor; (d) they are sold pursuant to Rule 144 or other applicable exemption; or (e) they are sold
pursuant to Regulation S under the 1933 Act (or a successor rule) (“Regulation S”), and the Purchaser shall have
delivered to the Company, at the cost of the Company, an opinion of counsel that shall be in form, substance and scope
customary for opinions of counsel in corporate transactions, which opinion shall be accepted by the Company; (ii) any sale is
made in reliance on Rule 144 may be made only in accordance with the terms of said Rule and further, if said Rule is not
applicable, any re-sale under circumstances in which the seller (or the person through whom the sale is made) may be deemed
to be an underwriter (as that term is defined in the 1933 Act) may require compliance with some other exemption under the
1933 Act or the rules and regulations of the SEC thereunder; and (iii) neither the Company nor any other person is under any
obligation to register such Securities under the 1933 Act or any state securities laws or to comply with the terms and
conditions of any exemption thereunder (in each case).

 

    2

     

    

 

g. Legends. The Purchaser understands
that until such time as the Note, and, upon conversion of the Note in accordance with its respective terms, the Conversion Shares,
have been registered under the 1933 Act or may be sold pursuant to Rule 144, Rule 144A under the 1933 Act, Regulation S, or other
applicable exemption without any restriction as to the number of securities as of a particular date that can then be immediately
sold, the Securities may bear a restrictive legend in substantially the following form (and a stop-transfer order may be placed
against transfer of the certificates for such Securities):

 

“NEITHER THE ISSUANCE AND SALE
OF THE SECURITIES REPRESENTED BY THIS CERTIFICATE NOR THE SECURITIES INTO WHICH THESE SECURITIES ARE [CONVERTIBLE/EXERCISABLE]
HAVE BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR APPLICABLE STATE SECURITIES LAWS. THE SECURITIES MAY NOT
BE OFFERED FOR SALE, SOLD, TRANSFERRED OR ASSIGNED (I) IN THE ABSENCE OF (A) AN EFFECTIVE REGISTRATION STATEMENT FOR THE SECURITIES
UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR (B) AN OPINION OF COUNSEL (WHICH COUNSEL SHALL BE SELECTED BY THE HOLDER), IN
A GENERALLY ACCEPTABLE FORM, THAT REGISTRATION IS NOT REQUIRED UNDER SAID ACT OR (II) UNLESS SOLD PURSUANT TO RULE 144, RULE 144A,
REGULATION S, OR OTHER APPLICABLE EXEMPTION UNDER SAID ACT. NOTWITHSTANDING THE FOREGOING, THE SECURITIES MAY BE PLEDGED IN CONNECTION
WITH A BONA FIDE MARGIN ACCOUNT OR OTHER LOAN OR FINANCING ARRANGEMENT SECURED BY THE SECURITIES.”

 

The legend set forth above shall be removed
and the Company shall issue a certificate for the applicable shares of Common Stock without such legend to the holder of any Security
upon which it is stamped or (as requested by such holder) issue the applicable shares of Common Stock to such holder by electronic
delivery by crediting the account of such holder’s broker with The Depository Trust Company (“DTC”), if,
unless otherwise required by applicable state securities laws, (a) such Security is registered for sale under an effective registration
statement filed under the 1933 Act or otherwise may be sold pursuant to Rule 144, Rule 144A, Regulation S, or other applicable
exemption without any restriction as to the number of securities as of a particular date that can then be immediately sold; or
(b) the Company or the Purchaser provides the Legal Counsel Opinion (as contemplated by and in accordance with Section 4(m) hereof)
to the effect that a public sale or transfer of such Security may be made without registration under the 1933 Act, which opinion
shall be accepted by the Company so that the sale or transfer is effected. The Company shall be responsible for the fees of its
transfer agent and all DTC fees associated with any such issuance. The Purchaser agrees to sell all Securities, including those
represented by a certificate(s) from which the legend has been removed, in compliance with applicable prospectus delivery requirements,
if any. In the event that the Company does not accept the opinion of counsel provided by the Purchaser with respect to the transfer
of Securities pursuant to an exemption from registration, such as Rule 144, Rule 144A, Regulation S, or other applicable exemption
at the Deadline (as defined in the Note), it will be considered an Event of Default pursuant to Section 3 of the Note.

 

    3

     

    

 

h. Authorization;
Enforcement. This Agreement has been duly and validly authorized by the Purchaser and has been duly executed and
delivered on behalf of the Purchaser, and this Agreement constitutes a valid and binding agreement of the Purchaser
enforceable in accordance with its terms, except as enforcement may be limited by bankruptcy, insolvency, reorganization,
moratorium or other similar laws affecting creditors’ rights generally and except as may be limited by the exercise of
judicial discretion in applying principles of equity.

 

i. Manipulation of Price. The Purchaser
has not, and to its knowledge no one acting on its behalf has: (i) taken, directly or indirectly, any action designed to cause
or to result, or that could reasonably be expected to cause or result, in the stabilization or manipulation of the price of any
security of the Company; (ii) sold, bid for, purchased, or paid any compensation for soliciting purchases of, any Stock in the
open market; or (iii) paid or agreed to pay to any person any compensation for soliciting another to purchase any other securities
of the Company.

 

j. No Shorting. Purchaser and its
affiliates shall be prohibited from engaging directly or indirectly in any short selling or hedging transactions with respect to
any securities of the Company while this Note is outstanding.

 

3. Representations and Warranties of the Company. The
Company represents and warrants to the Purchaser as of the Closing Date that:

 

a. Organization and Qualification.
The Company and each of its Subsidiaries (as defined below), if any, is a corporation duly organized, validly existing and in good
standing under the laws of the jurisdiction in which it is incorporated, with full power and authority (corporate and other) to
own, lease, use and operate its properties and to carry on its business as and where now owned, leased, used, operated and conducted.
Schedule 3(a), if attached hereto, sets forth a list of all of the Subsidiaries of the Company and the jurisdiction in which each
is incorporated. The Company and each of its Subsidiaries is duly qualified as a foreign corporation to do business and is in good
standing in every jurisdiction in which its ownership or use of property or the nature of the business conducted by it makes such
qualification necessary except where the failure to be so qualified or in good standing would not have a Material Adverse Effect.
“Material Adverse Effect” means any material adverse effect on the business, operations, assets, financial condition
or prospects of the Company or its Subsidiaries, if any, taken as a whole, or on the transactions contemplated hereby or by the
agreements or instruments to be entered into in connection herewith. “Subsidiaries” means any corporation or other
organization, whether incorporated or unincorporated, in which the Company owns, directly or indirectly, any equity or other ownership
interest.

 

b. Authorization; Enforcement. (i)
The Company has all requisite corporate power and authority to enter into and perform this Agreement, the Note, and to consummate
the transactions contemplated hereby and thereby and to issue the Securities, in accordance with the terms hereof and thereof;
(ii) the execution and delivery of this Agreement, the Note and the Shares by the Company and the consummation by it of the transactions
contemplated hereby and thereby (including without limitation, the issuance of the Note, as well as the issuance and reservation
for issuance of the Conversion Shares issuable upon conversion of the Note) have been duly authorized by the Company’s Board
of Directors and no further consent or authorization of the Company, its Board of Directors, its shareholders, or its debt holders
is required; (iii) this Agreement, the Note, and the Shares (together with any other instruments executed in connection herewith
or therewith) have been duly executed and delivered by the Company by its authorized representative, and such authorized representative
is the true and official representative with authority to sign this Agreement, the Note, the Shares and the other instruments documents
executed in connection herewith or therewith and bind the Company accordingly; and (iv) this Agreement constitutes, and upon execution
and delivery by the Company of the Note and the Shares, each of such instruments will constitute, a legal, valid and binding obligation
of the Company, enforceable against the Company in accordance with their terms.

 

    4

     

    

 

c. Capitalization;
Governing Documents. As of February 4, 2021, the authorized capital stock of the Company consists of: 150,000,000
authorized shares of Common Stock, of which 127,862,774 shares were outstanding. All of such outstanding shares of capital
stock of the Company, the Shares, and the Conversion Shares, are, or upon issuance will be, duly authorized, validly issued,
fully paid and non-assessable. No shares of capital stock of the Company are subject to preemptive rights or any other
similar rights of the shareholders of the Company or any liens or encumbrances imposed through the actions or failure to act
of the Company. As of the effective date of this Agreement, other than as publicly announced prior to such date and reflected
in the SEC Documents (as defined in this Agreement) of the Company (i) there are no outstanding options, warrants, scrip,
rights to subscribe for, puts, calls, rights of first refusal, agreements, understandings, claims or other commitments or
rights of any character whatsoever relating to, or securities or rights convertible into or exchangeable for any shares of
capital stock of the Company or any of its Subsidiaries, or arrangements by which the Company or any of its Subsidiaries is
or may become bound to issue additional shares of capital stock of the Company or any of its Subsidiaries; (ii) there are no
agreements or arrangements under which the Company or any of its Subsidiaries is obligated to register the sale of any of its
or their securities under the 1933 Act; and (iii) there are no anti-dilution or price adjustment provisions contained in any
security issued by the Company (or in any agreement providing rights to security holders) that will be triggered by the
issuance of any of the Securities. The Company has furnished to the Purchaser true and correct copies of the Company’s
Certificate of Incorporation as in effect on the date hereof (“Certificate of Incorporation”), the
Company’s Bylaws, as in effect on the date hereof (the “Bylaws”), and the terms of all securities
convertible into or exercisable for Common Stock of the Company and the material rights of the holders thereof in respect
thereto.

 

d. Issuance of the Shares and the Conversion
Shares. The Shares and the Conversion Shares are duly authorized and reserved for issuance and, upon issuance or upon the conversion
of the Note in accordance with its terms, will be validly issued, fully paid and non- assessable, and free from all taxes, liens,
claims and encumbrances with respect to the issue thereof and shall not be subject to preemptive rights or other similar rights
of shareholders of the Company and will not impose personal liability upon the holder thereof.

 

e. No Broker-Dealer Acknowledgement.
Absent a final adjudication from a court of competent jurisdiction stating otherwise, so long as any of the Shares or any amount
on the Note remains outstanding, the Company shall not to any person, institution, governmental or other entity, state, claim,
allege, or in any way assert, that Purchaser is currently, or ever has been a broker-dealer under the Securities Exchange Act of
1934.

 

f. Acknowledgment of Dilution. The
Company understands and acknowledges the potentially dilutive effect of the Conversion Shares to the Common Stock upon the conversion
of the Note. The Company further acknowledges that its obligation to issue the Conversion Shares, in accordance with this Agreement
and the Note are absolute and unconditional regardless of the dilutive effect that such issuance may have on the ownership interests
of other shareholders of the Company.

 

    5

     

    

 

g. Ranking; No
Conflicts. The Note shall be a subordinate debt obligation of the Company. The execution, delivery and performance of
this Agreement, the Note, and the Shares by the Company and the consummation by the Company of the transactions contemplated
hereby and thereby (including, without limitation, the issuance and reservation for issuance of the Conversion Shares) will
not (i) conflict with or result in a violation of any provision of the Certificate of Incorporation or Bylaws; or (ii)
violate or conflict with, or result in a breach of any provision of, or constitute a default (or an event which with notice
or lapse of time or both could become a default) under, or give to others any rights of termination, amendment, acceleration
or cancellation of, any agreement, note, evidence of indebtedness, indenture, patent, patent license or instrument to which
the Company or any of its Subsidiaries is a party; or (iii) result in a violation of any law, rule, regulation, order,
judgment or decree (including federal and state securities laws and regulations and regulations of any self-regulatory
organizations to which the Company or its securities is subject) applicable to the Company or any of its Subsidiaries or by
which any property or asset of the Company or any of its Subsidiaries is bound or affected (except for such conflicts,
defaults, terminations, amendments, accelerations, cancellations and violations as would not, individually or in the
aggregate, have a Material Adverse Effect); or (iv) trigger any anti-dilution and/or ratchet provision contained in any other
contract in which the Company is a party thereto or any security issued by the Company. Neither the Company nor any of its
Subsidiaries is in violation of its Certificate of Incorporation, Bylaws or other organizational documents and neither the
Company nor any of its Subsidiaries is in default (and no event has occurred which with notice or lapse of time or both could
put the Company or any of its Subsidiaries in default) under, and neither the Company nor any of its Subsidiaries has taken
any action or failed to take any action that would give to others any rights of termination, amendment, acceleration or
cancellation of, any agreement, indenture or instrument to which the Company or any of its Subsidiaries is a party or by
which any property or assets of the Company or any of its Subsidiaries is bound or affected, except for possible defaults as
would not, individually or in the aggregate, have a Material Adverse Effect. The businesses of the Company and its
Subsidiaries, if any, are not being conducted, and shall not be conducted so long as the Purchaser owns any of the
Securities, in violation of any law, ordinance or regulation of any governmental entity. Except as specifically contemplated
by this Agreement and as required under the 1933 Act and any applicable state securities laws, the Company is not required to
obtain any consent, authorization or order of, or make any filing or registration with, any court, governmental agency,
regulatory agency, self-regulatory organization or stock market or any third party in order for it to execute, deliver or
perform any of its obligations under this Agreement and the Note in accordance with the terms hereof or thereof or to issue
and sell the Note in accordance with the terms hereof and, upon conversion of the Note, issue Conversion Shares. All
consents, authorizations, orders, filings and registrations which the Company is required to obtain pursuant to the preceding
sentence have been obtained or effected on or prior to the date hereof. The Company and its Subsidiaries are unaware of any
facts or circumstances which might give rise to any of the foregoing.

 

h. SEC Documents; Financial Statements.
The Company has timely filed all reports, schedules, forms, statements and other documents required to be filed by it with the
SEC pursuant to the reporting requirements of the Securities Exchange Act of 1934, as amended (the “1934 Act”) (all
of the foregoing filed prior to the date hereof and all exhibits included therein and financial statements and schedules thereto
and documents (other than exhibits to such documents) incorporated by reference therein, being hereinafter referred to herein as
the “SEC Documents”). As of their respective dates, the SEC Documents complied in all material respects with the requirements
of the 1934 Act and the rules and regulations of the SEC promulgated thereunder applicable to the SEC Documents, and none of the
SEC Documents, at the time they were filed with the SEC, contained any untrue statement of a material fact or omitted to state
a material fact required to be stated therein or necessary in order to make the statements therein, in light of the circumstances
under which they were made, not misleading. None of the statements made in any such SEC Documents is, or has been, required to
be amended or updated under applicable law (except for such statements as have been amended or updated in subsequent filings prior
the date hereof). As of their respective dates, the financial statements of the Company included in the SEC Documents complied
as to form in all material respects with applicable accounting requirements and the published rules and regulations of the SEC
with respect thereto. Such financial statements have been prepared in accordance with United States generally accepted accounting
principles, consistently applied, during the periods involved and fairly present in all material respects the consolidated financial
position of the Company and its consolidated Subsidiaries as of the dates thereof and the consolidated results of their operations
and cash flows for the periods then ended (subject, in the case of unaudited statements, to normal year-end audit adjustments).
Except as set forth in the financial statements of the Company included in the SEC Documents, the Company has no liabilities, contingent
or otherwise, other than (i) liabilities incurred in the ordinary course of business subsequent to January 20, 2021, and (ii) obligations
under contracts and commitments incurred in the ordinary course of business and not required under generally accepted accounting
principles to be reflected in such financial statements, which, individually or in the aggregate, are not material to the financial
condition or operating results of the Company. The Company is subject to the reporting requirements of the 1934 Act. The Company
has never been a “shell company” as described in Rule 144(i)(1)(i).

 

    6

     

    

 

i. Absence of Certain Changes. Since
December 14, 2020, there has been no material adverse change and no material adverse development in the assets, liabilities, business,
properties, operations, financial condition, results of operations, prospects or 1934 Act reporting status of the Company or any
of its Subsidiaries.

 

j. Absence of Litigation. There
is no action, suit, claim, proceeding, inquiry or investigation before or by any court, public board, government agency, self-regulatory
organization or body pending or, to the knowledge of the Company or any of its Subsidiaries, threatened against or affecting the
Company or any of its Subsidiaries, or their officers or directors in their capacity as such, that could have a Material Adverse
Effect. The SEC Documents contain a complete list and summary description of any pending or, to the knowledge of the Company, threatened
proceeding against or affecting the Company or any of its Subsidiaries, without regard to whether it would have a Material Adverse
Effect. The Company and its Subsidiaries are unaware of any facts or circumstances which might give rise to any of the foregoing.
Notwithstanding the foregoing, the Purchaser acknowledges the existence of all litigations disclosed and outstanding the SEC Documents.

 

k. Intellectual Property. The Company
and each of its Subsidiaries owns or possesses the requisite licenses or rights to use all patents, patent applications, patent
rights, inventions, know-how, trade secrets, trademarks, trademark applications, service marks, service names, trade names and
copyrights (“Intellectual Property”) necessary to enable it to conduct its business as now operated (and, as presently
contemplated to be operated in the future); there is no claim or action by any person pertaining to, or proceeding pending, or
to the Company’s knowledge threatened, which challenges the right of the Company or of a Subsidiary with respect to any Intellectual
Property necessary to enable it to conduct its business as now operated (and, as presently contemplated to be operated in the future);
to the best of the Company’s knowledge, the Company’s or its Subsidiaries’ current and intended products, services
and processes do not infringe on any Intellectual Property or other rights held by any person; and the Company is unaware of any
facts or circumstances which might give rise to any of the foregoing. The Company and each of its Subsidiaries have taken reasonable
security measures to protect the secrecy, confidentiality and value of their Intellectual Property.

 

l. No Materially Adverse Contracts,
Etc. Neither the Company nor any of its Subsidiaries is subject to any charter, corporate or other legal restriction, or any
judgment, decree, order, rule or regulation which in the judgment of the Company’s officers has or is expected in the future
to have a Material Adverse Effect. Neither the Company nor any of its Subsidiaries is a party to any contract or agreement which
in the judgment of the Company’s officers has or is expected to have a Material Adverse Effect.

 

m. Tax Status. The Company and each
of its Subsidiaries has made or filed all federal, state and foreign income and all other tax returns, reports and declarations
required by any jurisdiction to which it is subject (unless and only to the extent that the Company and each of its Subsidiaries
has set aside on its books provisions reasonably adequate for the payment of all unpaid and unreported taxes) and has paid all
taxes and other governmental assessments and charges that are material in amount, shown or determined to be due on such returns,
reports and declarations, except those being contested in good faith and has set aside on its books provisions reasonably adequate
for the payment of all taxes for periods subsequent to the periods to which such returns, reports or declarations apply. There
are no unpaid taxes in any material amount claimed to be due by the taxing authority of any jurisdiction, and the officers of the
Company know of no basis for any such claim. The Company has not executed a waiver with respect to the statute of limitations relating
to the assessment or collection of any foreign, federal, state or local tax. None of the Company’s tax returns is presently
being audited by any taxing authority.

 

    7

     

    

 

n. Transactions
with Affiliates. Except for arm’s length transactions pursuant to which the Company or any of its Subsidiaries
makes payments in the ordinary course of business upon terms no less favorable than the Company or any of its Subsidiaries
could obtain from third parties and other than the grant of stock options described in the SEC Documents, none of the
officers, directors, or employees of the Company is presently a party to any transaction with the Company or any of its
Subsidiaries (other than for services as employees, officers and directors), including any contract, agreement or other
arrangement providing for the furnishing of services to or by, providing for rental of real or personal property to or from,
or otherwise requiring payments to or from any officer, director or such employee or, to the knowledge of the Company, any
corporation, partnership, trust or other entity in which any officer, director, or any such employee has a substantial
interest or is an officer, director, trustee or partner.

 

o. Disclosure. All information relating
to or concerning the Company or any of its Subsidiaries set forth in this Agreement and provided to the Purchaser pursuant to Section
2(d) hereof and otherwise in connection with the transactions contemplated hereby is true and correct in all material respects
and the Company has not omitted to state any material fact necessary in order to make the statements made herein or therein, in
light of the circumstances under which they were made, not misleading. No event or circumstance has occurred or exists with respect
to the Company or any of its Subsidiaries or its or their business, properties, prospects, operations or financial conditions,
which, under applicable law, rule or regulation, requires public disclosure or announcement by the Company but which has not been
so publicly announced or disclosed (assuming for this purpose that the Company’s reports filed under the 1934 Act are being
incorporated into an effective registration statement filed by the Company under the 1933 Act).

 

p. Acknowledgment Regarding Purchaser’s
Purchase of Securities. The Company acknowledges and agrees that the Purchaser is acting solely in the capacity of arm’s
length purchaser with respect to this Agreement and the transactions contemplated hereby. The Company further acknowledges that
the Purchaser is not acting as a financial advisor or fiduciary of the Company (or in any similar capacity) with respect to this
Agreement and the transactions contemplated hereby and any statement made by the Purchaser or any of its respective representatives
or agents in connection with this Agreement and the transactions contemplated hereby is not advice or a recommendation and is merely
incidental to the Purchaser’s purchase of the Securities. The Company further represents to the Purchaser that the Company’s
decision to enter into this Agreement has been based solely on the independent evaluation of the Company and its representatives.

 

q. No Integrated Offering. Neither
the Company, nor any of its affiliates, nor any person acting on its or their behalf, has directly or indirectly made any offers
or sales in any security or solicited any offers to buy any security under circumstances that would require registration under
the 1933 Act of the issuance of the Securities to the Purchaser. The issuance of the Securities to the Purchaser will not be integrated
with any other issuance of the Company’s securities (past, current or future) for purposes of any shareholder approval provisions
applicable to the Company or its securities.

 

r. No Brokers. The Company has taken
no action which would give rise to any claim by any person for brokerage commissions, transaction fees or similar payments relating
to this Agreement or the transactions contemplated hereby.

 

s. Permits;
Compliance. The Company and each of its Subsidiaries is in possession of all franchises, grants, authorizations,
licenses, permits, easements, variances, exemptions, consents, certificates, approvals and orders necessary to own, lease and
operate its properties and to carry on its business as it is now being conducted (collectively, the “Company
Permits”), and there is no action pending or, to the knowledge of the Company, threatened regarding suspension or
cancellation of any of the Company Permits. Neither the Company nor any of its Subsidiaries is in conflict with, or in
default or violation of, any of the Company Permits, except for any such conflicts, defaults or violations which,
individually or in the aggregate, would not reasonably be expected to have a Material Adverse Effect. Since January 20, 2021,
neither the Company nor any of its Subsidiaries has received any notification with respect to possible conflicts, defaults or
violations of applicable laws, except for notices relating to possible conflicts, defaults or violations, which conflicts,
defaults or violations would not have a Material Adverse Effect.

 

    8

     

    

 

t. Environmental Matters.

 

(i) There
are, to the Company’s knowledge, with respect to the Company or any of its Subsidiaries or any predecessor of the Company,
no past or present violations of Environmental Laws (as defined below), releases of any material into the environment, actions,
activities, circumstances, conditions, events, incidents, or contractual obligations which may give rise to any common law environmental
liability or any liability under the Comprehensive Environmental Response, Compensation and Liability Act of 1980 or similar federal,
state, local or foreign laws and neither the Company nor any of its Subsidiaries has received any notice with respect to any of
the foregoing, nor is any action pending or, to the Company’s knowledge, threatened in connection with any of the foregoing.
The term “Environmental Laws” means all federal, state, local or foreign laws relating to pollution or protection of
human health or the environment (including, without limitation, ambient air, surface water, groundwater, land surface or subsurface
strata), including, without limitation, laws relating to emissions, discharges, releases or threatened releases of chemicals, pollutants
contaminants, or toxic or hazardous substances or wastes (collectively, “Hazardous Materials”) into the environment,
or otherwise relating to the manufacture, processing, distribution, use, treatment, storage, disposal, transport or handling of
Hazardous Materials, as well as all authorizations, codes, decrees, demands or demand letters, injunctions, judgments, licenses,
notices or notice letters, orders, permits, plans or regulations issued, entered, promulgated or approved thereunder.

 

(ii) Other
than those that are or were stored, used or disposed of in compliance with applicable law, no Hazardous Materials are contained
on or about any real property currently owned, leased or used by the Company or any of its Subsidiaries, and no Hazardous Materials
were released on or about any real property previously owned, leased or used by the Company or any of its Subsidiaries during the
period the property was owned, leased or used by the Company or any of its Subsidiaries, except in the normal course of the Company’s
or any of its Subsidiaries’ business.

 

(iii) There
are no underground storage tanks on or under any real property owned, leased or used by the Company or any of its Subsidiaries
that are not in compliance with applicable law.

 

u. Title to Property. The Company
and its Subsidiaries have good and marketable title in fee simple to all real property and good and marketable title to all personal
property owned by them which is material to the business of the Company and its Subsidiaries, in each case free and clear of all
liens, encumbrances and defects except such as are described in Schedule 3(u), if attached hereto, or such as would not have a
Material Adverse Effect. Any real property and facilities held under lease by the Company and its Subsidiaries are held by them
under valid, subsisting and enforceable leases with such exceptions as would not have a Material Adverse Effect.

 

v. Insurance. The Company and each
of its Subsidiaries are insured by insurers of recognized financial responsibility against such losses and risks and in such amounts
as management of the Company believes to be prudent and customary in the businesses in which the Company and its Subsidiaries are
engaged. Neither the Company nor any such Subsidiary has any reason to believe that it will not be able to renew its existing insurance
coverage as and when such coverage expires or to obtain similar coverage from similar insurers as may be necessary to continue
its business at a cost that would not have a Material Adverse Effect. Upon written request the Company will provide to the Purchaser
true and correct copies of all policies relating to directors’ and officers’ liability coverage, errors and omissions
coverage, and commercial general liability coverage.

 

    9

     

    

 

w. Internal Accounting Controls.
The Company and each of its Subsidiaries maintain a system of internal accounting controls sufficient, in the judgment of the Company’s
board of directors, to provide reasonable assurance that (i) transactions are executed in accordance with management’s general
or specific authorizations; (ii) transactions are recorded as necessary to permit preparation of financial statements in conformity
with generally accepted accounting principles and to maintain asset accountability; (iii) access to assets is permitted only in
accordance with management’s general or specific authorization; and (iv) the recorded accountability for assets is compared
with the existing assets at reasonable intervals and appropriate action is taken with respect to any differences.

 

x. Foreign Corrupt Practices. Neither
the Company, nor any of its Subsidiaries, nor any director, officer, agent, employee or other person acting on behalf of the Company
or any Subsidiary has, in the course of his actions for, or on behalf of, the Company, used any corporate funds for any unlawful
contribution, gift, entertainment or other unlawful expenses relating to political activity; made any direct or indirect unlawful
payment to any foreign or domestic government official or employee from corporate funds; violated or is in violation of any provision
of the U.S. Foreign Corrupt Practices Act of 1977, as amended, or made any bribe, rebate, payoff, influence payment, kickback or
other unlawful payment to any foreign or domestic government official or employee.

 

y. Solvency. The Company (after
giving effect to the transactions contemplated by this Agreement) is solvent (i.e., its assets have a fair market value
in excess of the amount required to pay its probable liabilities on its existing debts as they become absolute and matured) and
currently the Company has no information that would lead it to reasonably conclude that the Company would not, after giving effect
to the transaction contemplated by this Agreement, have the ability to, nor does it intend to take any action that would impair
its ability to, pay its debts from time to time incurred in connection therewith as such debts mature. The Company’s financial
statements for its most recent fiscal year end and interim financial statements have been prepared assuming the Company will continue
as a going concern, which contemplates the realization of assets and the satisfaction of liabilities in the normal course of business.

 

z. No Investment Company. The Company
is not, and upon the issuance and sale of the Securities as contemplated by this Agreement will not be an “investment company”
required to be registered under the Investment Company Act of 1940 (an “Investment Company”). The Company is not controlled
by an Investment Company.

 

aa. No Off-Balance Sheet Arrangements.
There is no transaction, arrangement, or other relationship between the Company or any of its Subsidiaries and an unconsolidated
or other off- balance sheet entity that is required to be disclosed by the Company in its 1934 Act filings and is not so disclosed
or that otherwise could be reasonably likely to have a Material Adverse Effect.

 

bb. No Disqualification Events.
None of the Company, any of its predecessors, any affiliated issuer, any director, executive officer, other officer of the Company
participating in the offering hereunder, any beneficial owner of twenty percent (20%) or more of the Company’s outstanding
voting equity securities, calculated on the basis of voting power, nor any promoter (as that term is defined in Rule 405 under
the 1933 Act) connected with the Company in any capacity at the time of sale (each, an “Issuer Covered Person”) is
subject to any of the “Bad Actor” disqualifications described in Rule 506(d)(1)(i) to (viii) under the 1933 Act (a
“Disqualification Event”), except for a Disqualification Event covered by Rule 506(d)(2) or (d)(3). The Company has
exercised reasonable care to determine whether any Issuer Covered Person is subject to a Disqualification Event.

 

cc. Manipulation
of Price. The Company has not, and to its knowledge no one acting on its behalf has: (i) taken, directly or indirectly,
any action designed to cause or to result, or that could reasonably be expected to cause or result, in the stabilization or
manipulation of the price of any security of the Company to facilitate the sale or resale of any of the Securities, (ii)
sold, bid for, purchased, or paid any compensation for soliciting purchases of, any of the Securities, or (iii) paid or
agreed to pay to any person any compensation for soliciting another to purchase any other securities of the Company.

 

    10

     

    

 

dd. Bank Holding Company Act. Neither
the Company nor any of its Subsidiaries is subject to the Bank Holding Company Act of 1956, as amended (the “BHCA”)
and to regulation by the Board of Governors of the Federal Reserve System (the “Federal Reserve”). Neither the Company
nor any of its Subsidiaries or affiliates owns or controls, directly or indirectly, five percent (5%) or more of the outstanding
shares of any class of voting securities or twenty-five percent (25%) or more of the total equity of a bank or any entity that
is subject to the BHCA and to regulation by the Federal Reserve. Neither the Company nor any of its Subsidiaries or affiliates
exercises a controlling influence over the management or policies of a bank or any entity that is subject to the BHCA and to regulation
by the Federal Reserve.

 

ee. Illegal or Unauthorized Payments;
Political Contributions. Neither the Company nor any of its Subsidiaries nor, to the Company’s knowledge, any of the
officers, directors, employees, agents or other representatives of the Company or any of its Subsidiaries or any other business
entity or enterprise with which the Company or any Subsidiary is or has been affiliated or associated, has, directly or indirectly,
made or authorized any payment, contribution or gift of money, property, or services, whether or not in contravention of applicable
law, (i) as a kickback or bribe to any person; or (ii) to any political organization, or the holder of or any aspirant to any elective
or appointive public office except for personal political contributions not involving the direct or indirect use of funds of the
Company or any of its Subsidiaries.

 

ff. Breach of Representations and Warranties
by the Company. The Company agrees that if the Company breaches any of the representations or warranties set forth in this
Section 3 and in addition to any other remedies available to the Purchaser pursuant to this Agreement, it will be considered an
Event of Default under Section 3 of the Note.

 

4. ADDITIONAL COVENANTS, AGREEMENTS AND ACKNOWLEDGEMENTS.

 

a. Best Efforts. The parties shall
use their best efforts to satisfy timely each of the conditions described in Section 6 and 7 of this Agreement.

 

b. Use of Proceeds. The Company
shall use the proceeds for repayment of existing debt, with each debt disclosed in Schedule 4(b) attached hereto, and for general
working capital purposes. Notwithstanding the foregoing, the proceeds shall not be used for the repayment of existing indebtedness
of the Company owed to officers, directors or employees of the Company or their affiliates or in violation or contravention of
any applicable law, rule or regulation.

 

c. Usury.
To the extent it may lawfully do so, the Company hereby agrees not to insist upon or plead or in any manner whatsoever claim,
and will resist any and all efforts to be compelled to take the benefit or advantage of, usury laws wherever enacted, now or
at any time hereafter in force, in connection with any action or proceeding that may be brought by the Purchaser in order to
enforce any right or remedy under this Agreement, the Note and any document, agreement or instrument contemplated thereby.
Notwithstanding any provision to the contrary contained in this Agreement, the Note and any document, agreement or instrument
contemplated thereby, it is expressly agreed and provided that the total liability of the Company under this Agreement, the
Note or any document, agreement or instrument contemplated thereby for payments which under applicable law are in the nature
of interest shall not exceed the maximum lawful rate authorized under applicable law (the “Maximum Rate”), and,
without limiting the foregoing, in no event shall any rate of interest or default interest, or both of them, when aggregated
with any other sums which under applicable law in the nature of interest that the Company may be obligated to pay under this
Agreement, the Note and any document, agreement or instrument contemplated thereby exceed such Maximum Rate. It is agreed
that if the maximum contract rate of interest allowed by law applicable to this Agreement, the Note and any document,
agreement or instrument contemplated thereby is increased or decreased by statute or any official governmental action
subsequent to the date hereof, the new maximum contract rate of interest allowed by law will be the Maximum Rate applicable
to this Agreement, the Note and any document, agreement or instrument contemplated thereby from the effective date thereof
forward, unless such application is precluded by applicable law. If under any circumstances whatsoever, interest in excess of
the Maximum Rate is paid by the Company to the Purchaser with respect to indebtedness evidenced by this Agreement, the Note
and any document, agreement or instrument contemplated thereby, such excess shall be applied by the Purchaser to the unpaid
principal balance of any such indebtedness or be refunded to the Company, the manner of handling such excess to be at the
Purchaser’s election.

 

    11

     

    

 

d. Restriction on Activities. Commencing
as of the date first above written, and so long as the Purchaser owns any of the Securities, the Company shall not, directly or
indirectly, without the Purchaser’s prior written consent, which consent shall not be unreasonably withheld: (a) change the
nature of its business in any material respect; or (b) sell, divest, acquire, change the structure of any material assets other
than in the ordinary course of business.

 

e. Listing. The Company, for so
long as the Purchaser owns any of the Securities, will maintain the listing and trading of its Common Stock on the Principal Market
or any equivalent replacement exchange or electronic quotation system (including but not limited to the Pink Sheets electronic
quotation system) and will comply in all respects with the Company’s reporting, filing and other obligations under the bylaws
or rules of the Financial Industry Regulatory Authority (“FINRA”) and such exchanges, as applicable. The Company shall
promptly provide to the Purchaser copies of any notices it receives from the Principal Market and any other exchanges or electronic
quotation systems on which the Common Stock is then traded regarding the continued eligibility of the Common Stock for listing
on such exchanges and quotation systems.

 

f. Corporate
Existence. The Company will, so long as the Purchaser beneficially owns any of the Securities, maintain its corporate
existence and shall not sell all or substantially all of the Company’s assets, except in the event of a merger or
consolidation or sale of all or substantially all of the Company’s assets, where the surviving or successor entity in
such transaction (i) assumes the Company’s obligations hereunder and under the agreements and instruments entered into
in connection herewith and (ii) is a publicly traded corporation whose Common Stock is listed for trading or quotation on the
Principal Market, any tier of the NASDAQ Stock Market, the New York Stock Exchange or the NYSE MKT.

 

g. No Integration. The Company shall
not make any offers or sales of any security (other than the Securities) under circumstances that would require registration of
the Securities being offered or sold hereunder under the 1933 Act or cause the offering of the Securities to be integrated with
any other offering of securities by the Company for the purpose of any stockholder approval provision applicable to the Company
or its securities.

 

h. Breach of Covenants. The Company
acknowledges and agrees that if the Company breaches any of the covenants set forth in this Section 4, in addition to any other
remedies available to the Purchaser pursuant to this Agreement, it will be considered an Event of Default under Section 3 of the
Note.

 

    12

     

    

 

i. Compliance
with 1934 Act; Public Information Failures. For so long as the Purchaser beneficially owns the Note, the Shares, or any
Conversion Shares, the Company shall comply with the reporting requirements of the 1934 Act; and the Company shall continue
to be subject to the reporting requirements of the 1934 Act. During the period that the Purchaser beneficially owns the Note,
if the Company shall (i) fail for any reason to satisfy the requirements of Rule 144(c)(1), including, without limitation,
the failure to satisfy the current public information requirements under Rule 144(c) or (ii) if the Company has ever been an
issuer described in Rule 144(i)(1)(i) or becomes such an issuer in the future, and the Company shall fail to satisfy any
condition set forth in Rule 144(i)(2) (each, a “Public Information Failure”) then, as partial relief for the
damages to the Purchaser by reason of any such delay in or reduction of its ability to sell the Securities (which remedy
shall not be exclusive of any other remedies available pursuant to this Agreement, the Note, or at law or in equity), the
Company shall pay to the Purchaser an amount in cash equal to three percent (3%) of the Purchase Price on each of the day of
a Public Information Failure and on every thirtieth day (pro-rated for periods totaling less than thirty days) thereafter
until the date such Public Information Failure is cured. The payments to which a holder shall be entitled pursuant to this
Section 4(k) are referred to herein as “Public Information Failure Payments.” Public Information Failure Payments
shall be paid on the earlier of (i) the last day of the calendar month during which such Public Information Failure Payments
are incurred and (iii) the third business day after the event or failure giving rise to the Public Information Failure
Payments is cured. In the event the Company fails to make Public Information Failure Payments in a timely manner, such Public
Information Failure Payments shall bear interest at the rate of eight percent (8%) per month (prorated for partial months)
until paid in full. As used in this Agreement, the term “business day” shall mean any day other than a Saturday,
Sunday or a day on which commercial banks in the city of New York, New York are authorized or required by law or executive
order to remain closed.

 

j. Disclosure of Transactions and Other
Material Information. By 9:00 a.m., New York time, three (3) Business Days following the date this Agreement has been fully
executed and funded, the Company shall file a Current Report on Form 8-K describing the terms of the transactions contemplated
by this Agreement in the form required by the 1934 Act and attaching this Agreement, the form of Note (the “8-K Filing”).
From and after the filing of the 8-K Filing with the SEC, the Purchaser shall not be in possession of any material, nonpublic information
received from the Company, any of its Subsidiaries or any of their respective officers, directors, employees or agents that is
not disclosed in the 8-K Filing. In addition, effective upon the filing of the 8-K Filing, the Company acknowledges and agrees
that any and all confidentiality or similar obligations under any agreement, whether written or oral, between the Company, any
of its Subsidiaries or any of their respective officers, directors, affiliates, employees or agents, on the one hand, and the Purchaser
or any of its affiliates, on the other hand, shall terminate.

 

k. Legal Counsel Opinions. Upon
the request of the Purchaser from to time to time, the Company shall be responsible, at its cost, for promptly supplying to the
Company’s transfer agent and the Purchaser a customary legal opinion letter (the “Legal Counsel Opinion”) to
the effect that the resale of the Conversion Shares by the Purchaser or its affiliates, successors and assigns is exempt from the
registration requirements of the 1933 Act pursuant to Rule 144, provided the requirements of Rule 144 are satisfied and provided
the Conversion Shares are not then registered under the 1933 Act for resale pursuant to an effective registration statement, or
other applicable exemption, provided the requirements of such other applicable exemption are satisfied. Purchaser will take no
action or inaction that would invalidate the proposed opinion. Purchaser will provide the customary representations to counsel
in order to provide such an opinion. The Purchaser may, at the Company’s cost, secure legal counsel to issue the Legal Counsel
Opinion, and the Company will instruct its transfer agent to accept such opinion. The Company hereby agrees that it may never take
the position that it is a “shell company” in connection with its obligations under this Agreement or otherwise.

 

l. [reserved]

 

m. Non-Public
Information. The Company covenants and agrees that neither it, nor any other person acting on its behalf will provide the
Purchaser or its agents or counsel with any information that constitutes, or the Company reasonably believes constitutes,
material non-public information, unless prior thereto the Purchaser shall have consented to the receipt of such information
and agreed with the Company to keep such information confidential. The Company understands and confirms that the Purchaser
shall be relying on the foregoing covenant in effecting transactions in securities of the Company. To the extent that the
Company delivers any material, non-public information to the Purchaser without such Purchaser’s consent, the Company
hereby covenants and agrees that such Purchaser shall not have any duty of confidentiality to the Company, any of its
Subsidiaries, or any of their respective officers, directors, agents, employees or affiliates, not to trade on the basis of,
such material, non-public information, provided that the Purchaser shall remain subject to applicable law. To the extent that
any notice provided, information provided, or any other communications made by the Company, to the Purchaser, constitutes or
contains material non-public information regarding the Company or any Subsidiaries, the Company shall simultaneously file
such notice or other material information with the SEC pursuant to a Current Report on Form 8-K. In addition to any other
remedies provided by this Agreement or the related transaction documents, if the Company provides any material non-public
information to the Purchaser without their prior written consent, and it fails to immediately (no later than that business
day) file a Form 8-K disclosing this material non-public information, it shall pay the Purchaser as partial liquidated
damages and not as a penalty a sum equal to $3,000 per day beginning with the day the information is disclosed to the
Purchaser and ending and including the day the Form 8-K disclosing this information is filed.

 

    13

     

    

 

n. [reserved]

 

o. [reserved]

 

(p) Pending Rulemaking. As of the
Issue Date hereof, proposed rulemaking exists, namely proposed amendments to Rule 144(d)(3)(ii) proposed on December 22, 2020 in
SEC Release 2020-336, that would fundamentally change the economic terms of the transaction contemplated by this Agreement, including
the Shares. In the event the rulemaking becomes final, substantially in the form as proposed, any pricing mechanism that is deemed
thereunder to be a market-adjustable price shall be automatically amended to be a fixed price of $0.05 consistent with the fixed
price terms of the Note.

 

(q) Cross-Default. The parties are
entering in this Agreement in connection with other agreements, including but not limited to, an Exchange Agreement and an Exchange
Note, dated as of even date herewith (collectively, the “Transaction Documents”). Any Event of Default under any of
the Transaction Documents shall constitute an Event of Default of each of the Transaction Documents.

 

As used in this Agreement, the term “business
day” shall mean any day other than a Saturday, Sunday or a day on which commercial banks in the city of New York, New York
are authorized or required by law or executive order to remain closed.

 

5. Transfer
Agent Instructions. The Company shall issue irrevocable instructions to the Company’s transfer agent to issue
certificates, or in book entry, registered in the name of the Purchaser or its nominee, upon conversion of the Note, the
Conversion Shares, in such amounts as specified from time to time by the Purchaser to the Company in accordance with the
terms thereof (the “Irrevocable Transfer Agent Instructions”). In the event that the Company proposes to replace
its transfer agent, the Company shall provide, prior to the effective date of such replacement, a fully executed Irrevocable
Transfer Agent Instructions in a form as initially delivered pursuant to this Agreement (including but not limited to the
provision to irrevocably reserved shares of Common Stock in the Reserved Amount (as defined in the Note)) signed by the
successor transfer agent to the Company and the Company. Prior to registration of the Conversion Shares under the 1933 Act or
the date on which the Conversion Shares may be sold pursuant to Rule 144, Rule 144A, Regulation S, or other applicable
exemption without any restriction as to the number of Securities as of a particular date that can then be immediately sold,
all such certificates or shares evidenced by book entry shall bear the restrictive legend specified in Section 2(g) of this
Agreement. The Company warrants that: (i) no instruction other than the Irrevocable Transfer Agent Instructions referred to
in this Section 5 will be given by the Company to its transfer agent and that the Securities shall otherwise be freely
transferable on the books and records of the Company as and to the extent provided in this Agreement and the Note; (ii) it
will not direct its transfer agent not to transfer or delay, impair, and/or hinder its transfer agent in transferring (or
issuing)(electronically or in certificated form) any certificate or book entry for Securities to be issued to the Purchaser
upon conversion of or otherwise pursuant to the Note as and when required by the Note and this Agreement; (iii) it will not
fail to remove (or directs its transfer agent not to remove or impairs, delays, and/or hinders its transfer agent from
removing) any restrictive legend (or to withdraw any stop transfer instructions in respect thereof) on any certificate or
book entry for any Securities issued to the Purchaser upon conversion of or otherwise pursuant to the Note as and when
required by the Note and this Agreement; and (iv) it will provide any required corporate resolutions and issuance approvals
to its transfer agent within six (6) hours of each conversion of the Note. Nothing in this Section shall affect in any way
the Purchaser’s obligations and agreement set forth in Section 2(g) hereof to comply with all applicable prospectus
delivery requirements, if any, upon re-sale of the Securities. If the Purchaser provides the Company, at the cost of the
Company, with (i) an opinion of counsel in form, substance and scope customary for opinions in comparable transactions, to
the effect that a public sale or transfer of such Securities may be made without registration under the 1933 Act and such
sale or transfer is effected or (ii) the Purchaser provides reasonable assurances that the Securities can be sold pursuant to
Rule 144, Rule 144A, Regulation S, or other applicable exemption, the Company shall permit the transfer, and, in the case of
the Securities, promptly instruct its transfer agent to issue one or more certificates, free from restrictive legend, in such
name and in such denominations as specified by the Purchaser. The Company acknowledges that a breach by it of its obligations
hereunder will cause irreparable harm to the Purchaser, by vitiating the intent and purpose of the transactions contemplated
hereby. Accordingly, the Company acknowledges that the remedy at law for a breach of its obligations under this Section 5 may
be inadequate and agrees, in the event of a breach or threatened breach by the Company of the provisions of this Section,
that the Purchaser shall be entitled, in addition to all other available remedies, to an injunction restraining any breach
and requiring immediate transfer, without the necessity of showing economic loss and without any bond or other security being
required.

 

    14

     

    

 

6. Conditions to the Company’s
Obligation to Sell. The obligation of the Company hereunder to issue and sell the Note and the Shares to the Purchaser at the
Closing is subject to the satisfaction, at or before the Closing Date, of each of the following conditions thereto, provided that
these conditions are for the Company’s sole benefit and may be waived by the Company at any time in its sole discretion:

 

a. The Purchaser shall have executed this
Agreement and delivered the same to the Company.

 

b. The Purchaser shall have delivered the
Purchase Price in accordance with Section 1(b) above.

 

c. The representations and warranties of
the Purchaser shall be true and correct in all material respects as of the date when made and as of the Closing Date, as though
made at that time (except for representations and warranties that speak as of a specific date), and the Purchaser shall have performed,
satisfied and complied in all material respects with the covenants, agreements and conditions required by this Agreement to be
performed, satisfied or complied with by the Purchaser at or prior to the Closing Date.

 

d. No litigation, statute, rule, regulation,
executive order, decree, ruling or injunction shall have been enacted, entered, promulgated or endorsed by or in any court or governmental
authority of competent jurisdiction or any self-regulatory organization having authority over the matters contemplated hereby which
prohibits the consummation of any of the transactions contemplated by this Agreement.

 

    15

     

    

 

7. Conditions to The Purchaser’s
Obligation to Purchase. The obligation of the Purchaser hereunder to purchase the Note, on the Closing Date, is subject to
the satisfaction, at or before the Closing Date, of each of the following conditions, provided that these conditions are for the
Purchaser’s sole benefit and may be waived by the Purchaser at any time in its sole discretion:

 

a. The Company shall have executed this
Agreement and delivered the same to the Purchaser.

 

b. The Company shall have delivered to
the Purchaser the duly executed Note in such denominations as the Purchaser shall request and in accordance with Section 1(b) above.

 

c. The Irrevocable Transfer Agent Instructions,
in form and substance satisfactory to the Purchaser, shall have been delivered to and acknowledged in writing by the Company’s
Transfer Agent.

 

d. The representations and warranties of
the Company shall be true and correct in all material respects as of the date when made and as of Closing Date, as though made
at such time (except for representations and warranties that speak as of a specific date) and the Company shall have performed,
satisfied and complied in all material respects with the covenants, agreements and conditions required by this Agreement to be
performed, satisfied or complied with by the Company at or prior to the Closing Date.

 

e. No litigation, statute, rule, regulation,
executive order, decree, ruling or injunction shall have been enacted, entered, promulgated or endorsed by or in any court or governmental
authority of competent jurisdiction or any self-regulatory organization having authority over the matters contemplated hereby which
prohibits the consummation of any of the transactions contemplated by this Agreement.

 

f. No event shall have occurred which could
reasonably be expected to have a Material Adverse Effect on the Company including but not limited to a change in the 1934 Act reporting
status of the Company or the failure of the Company to be timely in its 1934 Act reporting obligations.

 

g. The Company shall have delivered to
the Purchaser resolutions adopted by the Company’s Board of Directors at a duly called meeting or by unanimous written consent
authorizing this Agreement and all other documents, instruments and transactions contemplated hereby.

 

8. Governing Law; Miscellaneous.

 

a. Governing Law; Venue. This Agreement
shall be governed by and construed in accordance with the laws of the State of New York without regard to principles of conflicts
of laws. Any action brought by either party against the other concerning the transactions contemplated by this Agreement, the Note,
or any other agreement, certificate, instrument or document contemplated hereby shall be brought only in the state courts of New
York or in the federal courts located in the state of New York. The parties to this Agreement hereby irrevocably waive any objection
to jurisdiction and venue of any action instituted hereunder and shall not assert any defense based on lack of jurisdiction or
venue or based upon forum non conveniens. EACH PARTY HEREBY IRREVOCABLY WAIVES ANY RIGHT IT MAY HAVE, AND AGREES NOT
TO REQUEST, A JURY TRIAL FOR THE ADJUDICATION OF ANY DISPUTE HEREUNDER OR IN CONNECTION WITH OR ARISING OUT OF THIS AGREEMENT OR
ANY TRANSACTIONS CONTEMPLATED HEREBY. The prevailing party shall be entitled to recover from the other party its reasonable
attorney’s fees and costs. Each party hereby irrevocably waives personal service of process and consents to process being
served in any suit, action or proceeding in connection with this Agreement, the Note, the Shares, or any other agreement, certificate,
instrument or document contemplated hereby or thereby by mailing a copy thereof via registered or certified mail or overnight delivery
(with evidence of delivery) to such party at the address in effect for notices to it under this Agreement and agrees that such
service shall constitute good and sufficient service of process and notice thereof. Nothing contained herein shall be deemed to
limit in any way any right to serve process in any other manner permitted by law.

 

    16

     

    

 

b. Counterparts. This Agreement
may be executed in one or more counterparts, each of which shall be deemed an original but all of which shall constitute one and
the same agreement and shall become effective when counterparts have been signed by each party and delivered to the other party.
A facsimile or .pdf signature shall be considered due execution and shall be binding upon the signatory thereto with the same force
and effect as if the signature were an original, not a facsimile or .pdf signature. Delivery of a counterpart signature hereto
by facsimile or email/.pdf transmission shall be deemed validly delivery thereof.

 

c. Construction; Headings. This
Agreement shall be deemed to be jointly drafted by the Company and the Purchaser and shall not be construed against any person
as the drafter hereof. The headings of this Agreement are for convenience of reference only and shall not form part of, or affect
the interpretation of, this Agreement.

 

d. Severability. In the event that
any provision of this Agreement, the Note, or any other agreement or instrument delivered in connection herewith is invalid or
unenforceable under any applicable statute or rule of law, then such provision shall be deemed inoperative to the extent that it
may conflict therewith and shall be deemed modified to conform with such statute or rule of law. Any such provision which may prove
invalid or unenforceable under any law shall not affect the validity or enforceability of any other provision of this Agreement,
the Note, the Shares, or any other agreement, certificate, instrument or document contemplated hereby or thereby.

 

e. Entire Agreement; Amendments.
This Agreement, the Note, the Shares, and the instruments referenced herein contain the entire understanding of the parties with
respect to the matters covered herein and therein and, except as specifically set forth herein or therein, neither the Company
nor the Purchaser makes any representation, warranty, covenant or undertaking with respect to such matters. No provision of this
Agreement or any agreement or instrument contemplated hereby may be waived or amended other than by an instrument in writing signed
by the Purchaser.

 

    17

     

    

 

f. Notices. All notices, demands,
requests, consents, approvals, and other communications required or permitted hereunder shall be in writing and, unless otherwise
specified herein, shall be (i) personally served; (ii) deposited in the mail, registered or certified, return receipt requested,
postage prepaid; (iii) delivered by reputable air courier service with charges prepaid, or (iv) transmitted by hand delivery, telegram,
e-mail or facsimile, addressed as set forth below or to such other address as such party shall have specified most recently by
written notice. Any notice or other communication required or permitted to be given hereunder shall be deemed effective (a) upon
hand delivery or delivery by e-mail or facsimile, with accurate confirmation generated by the transmitting facsimile machine, at
the address or number designated below (if delivered on a business day during normal business hours where such notice is to be
received), or the first business day following such delivery (if delivered other than on a business day during normal business
hours where such notice is to be received) or (b) on the second business day following the date of mailing by express courier service,
fully prepaid, addressed to such address, or upon actual receipt of such mailing, whichever shall first occur. The addresses for
such communications shall be:

 

If to the Company, to:

 

DIGERATI TECHNOLOGIES, INC.

825 W. Bitters, Suite 104

San Antonio, Texas 78216

Attention:
Arthur Smith

e-mail:

 

If to the Purchaser:

 

PLATINUM POINT CAPITAL, LLC

353 Lexington Avenue, Suite 1502

New York, New York 10016

Attention:
Brian Freifeld, President

e-mail: brian@platinumpointcap.com

 

With a copy by e-mail only to (which copy shall not constitute
notice):

 

FABIAN VANCOTT

215 South State Street, Suite 1200

Salt Lake City, Utah 84111

Attn: Anthony Michael Panek

e-mail: apanek@fabianvancott.com

 

To the address included on its subscription page attached hereto

 

g. Successors and Assigns. This
Agreement shall be binding upon and inure to the benefit of the parties and their successors and assigns. Neither the Company nor
the Purchaser shall assign this Agreement or any rights or obligations hereunder without the prior written consent of the other.
Notwithstanding the foregoing, subject to Section 2(f), the Purchaser may assign its rights hereunder to any person that purchases
Securities in a private transaction from the Purchaser or to any of its “affiliates,” as that term is defined under
the 1934 Act, without the consent of the Company.

 

h. Third Party Beneficiaries. This
Agreement is intended for the benefit of the parties hereto and their respective permitted successors and assigns, and is not for
the benefit of, nor may any provision hereof be enforced by, any other person.

 

i. Survival. The representations
and warranties of the Company and the agreements and covenants set forth in this Agreement shall survive the closing hereunder
notwithstanding any due diligence investigation conducted by or on behalf of the Purchaser. The Company agrees to indemnify and
hold harmless the Purchaser and all their officers, directors, employees and agents for loss or damage arising as a result of or
related to any breach or alleged breach by the Company of any of its representations, warranties, and covenants set forth in this
Agreement or any of its covenants and obligations under this Agreement, including advancement of expenses as they are incurred.

 

j. Publicity. The Company, and the
Purchaser shall have the right to review a reasonable period of time before issuance of any press releases, SEC, Principal Market
or FINRA filings, or any other public statements with respect to the transactions contemplated hereby; provided, however,
that the Company shall be entitled, without the prior approval of the Purchaser, to make any press release or SEC, Principal Market
(or other applicable trading market) or FINRA filings with respect to such transactions as is required by applicable law and regulations
(although the Purchaser shall be consulted by the Company in connection with any such press release prior to its release and shall
be provided with a copy thereof and be given an opportunity to comment thereon).

 

    18

     

    

 

k. Expense Reimbursement; Further Assurances.
At the Closing to occur as of the Closing Date, the Company shall pay on behalf of the Purchaser or reimburse the Purchaser for
its legal fees and expenses incurred in connection with this Agreement, pursuant to the disbursement authorization signed by the
Company of even date. Each party shall do and perform, or cause to be done and performed, all such further acts and things, and
shall execute and deliver all such other agreements, certificates, instruments and documents, as the other party may reasonably
request in order to carry out the intent and accomplish the purposes of this Agreement and the consummation of the transactions
contemplated hereby.

 

l. No Strict Construction. The
language used in this Agreement will be deemed to be the language chosen by the parties to express their mutual intent, and
no rules of strict construction will be applied against any party.

 

m. Indemnification. In consideration
of the Purchaser’s execution and delivery of this Agreement and acquiring the Securities hereunder, and in addition to all
of the Company’s other obligations under this Agreement or the Note, the Company shall defend, protect, indemnify and hold
harmless the Purchaser and its stockholders, partners, members, officers, directors, employees and direct or indirect investors
and any of the foregoing persons’ agents or other representatives (including, without limitation, those retained in connection
with the transactions contemplated by this Agreement) (collectively, the “Indemnitees”) from and against any and all
third party actions, causes of action, suits, claims, losses, costs, penalties, fees, liabilities and damages, and expenses in
connection therewith (irrespective of whether any such Indemnitee is a party to the action for which indemnification hereunder
is sought), and including reasonable attorneys’ fees and disbursements (the “Indemnified Liabilities”), incurred
by any Indemnitee as a result of, or arising out of, or relating to (a) any misrepresentation or breach of any representation or
warranty made by the Company in this Agreement, the Note or any other agreement, certificate, instrument or document contemplated
hereby or thereby, (b) any breach of any covenant, agreement or obligation of the Company contained in this Agreement, the Note
or any other agreement, certificate, instrument or document contemplated hereby or thereby or (c) any cause of action, suit or
claim brought or made against such Indemnitee by a third party (including for these purposes a derivative action brought on behalf
of the Company) and arising out of or resulting from (i) the execution, delivery, performance or enforcement of this Agreement,
the Note or any other agreement, certificate, instrument or document contemplated hereby or thereby, (ii) any transaction financed
or to be financed in whole or in part, directly or indirectly, with the proceeds of the issuance of the Securities, or (iii) the
status of the Purchaser or holder of the Securities as an investor in the Company pursuant to the transactions contemplated by
this Agreement. To the extent that the foregoing undertaking by the Company may be unenforceable for any reason, the Company shall
make the maximum contribution to the payment and satisfaction of each of the Indemnified Liabilities that is permissible under
applicable law.

 

n. Remedies. The Company acknowledges
that a breach by it of its obligations hereunder will cause irreparable harm to the Purchaser by vitiating the intent and purpose
of the transaction contemplated hereby. Accordingly, the Company acknowledges that the remedy at law for a breach of its obligations
under this Agreement or the Note will be inadequate and agrees, in the event of a breach or threatened breach by the Company of
the provisions of this Agreement, the Note, or the Shares, that the Purchaser shall be entitled, in addition to all other available
remedies at law or in equity, and in addition to the penalties assessable herein, to an injunction or injunctions restraining,
preventing or curing any breach of this Agreement or the Note and to enforce specifically the terms and provisions hereof, without
the necessity of showing economic loss and without any bond or other security being required.

 

o. Payment Set Aside. To the extent
that the Company makes a payment or payments to the Purchaser hereunder or pursuant to the Note, or the Purchaser enforces or exercises
its rights hereunder or thereunder, and such payment or payments or the proceeds of such enforcement or exercise or any part thereof
are subsequently invalidated, declared to be fraudulent or preferential, set aside, recovered from, disgorged by or are required
to be refunded, repaid or otherwise restored to the Company, a trustee, receiver or any other person or entity under any law (including,
without limitation, any bankruptcy law, foreign, state or federal law, common law or equitable cause of action), then to the extent
of any such restoration the obligation or part thereof originally intended to be satisfied shall be revived and continued in full
force and effect as if such payment had not been made or such enforcement or setoff had not occurred.

 

p. Failure or Indulgence Not Waiver.
No failure or delay on the part of the Purchaser in the exercise of any power, right or privilege hereunder shall operate as a
waiver thereof, nor shall any single or partial exercise of any such power, right or privilege preclude other or further exercise
thereof or of any other right, power or privileges. All rights and remedies of the Purchaser existing hereunder are cumulative
to, and not exclusive of, any rights or remedies otherwise available.

 

[SIGNATURE PAGE FOLLOWS]

 

    19

     

    

 

IN WITNESS WHEREOF, the undersigned Purchaser and the Company
have caused this Agreement to be duly executed as of the date first above written.

 

	DIGERATI TECHNOLOGIES, INC.	 
	 	 	 
	By:	/s/ Arthur Smith	 
	 	Name: 	Arthur Smith	 
	 	Title:	 Chief Executive Officer	 

 

	PURCHASER	 
	 	 
	PLATINUM POINT CAPITAL, LLC	 
	 	 	 
	By:	/s/ Brian Freifeld	 
	 	Name: 	Brian Freifeld	 
	 	Title:	President	 

 

SUBSCRIPTION AMOUNT:

 

Principal Amount of Note: $175,000.00

Actual Amount of Purchase Price of Note: $175,000.00*

 

*The purchase price of $175,000.00 shall be paid promptly after
the full execution of the Note and related transaction documents.

 

    20

     

    

 

EXHIBIT A

 

FORM OF NOTE

 

[attached hereto]

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00324-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00324-of-00352.parquet"}]]